WO2026108938 - AMORPHOUS FORM OF COMPOUND A OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING AMORPHOUS FORM
National phase entry is expected:
Publication Number
WO/2026/108938
Publication Date
28.05.2026
International Application No.
PCT/CN2025/136549
International Filing Date
20.11.2025
Title **
[English]
AMORPHOUS FORM OF COMPOUND A OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING AMORPHOUS FORM
[French]
FORME AMORPHE D'UN COMPOSÉ A OU D'UN SEL DE CELUI-CI ET COMPOSITION PHARMACEUTIQUE COMPRENANT UNE FORME AMORPHE
[Chinese]
一种化合物A或其盐的无定型以及包含该无定形的药物组合物
Applicants **
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD
Inventors
LI, Qinze
LI, Song
LIAN, Xiaolei
WANG, Zhigang
LU, Yinsuo
HUA, Huaijie
ZOU, Peng
Priority Data
202411666528.2
20.11.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1776 | |
| EPO | Filing, Examination, Granting | 12610 | |
| Japan | Filing, Examination, Granting | 2241 | |
| South Korea | Filing, Examination, Granting | 2237 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
23,604
Contact Us
Abstract[English]
The present invention relates to the field of chemical drug technology, and in particular, to an amorphous form of compound A or a salt thereof, and a pharmaceutical composition comprising the amorphous form.[French]
La présente invention relève du domaine de la technologie des médicaments chimiques, et concerne en particulier, une forme amorphe du composé A ou d'un sel de celui-ci, et une composition pharmaceutique comprenant la forme amorphe.[Chinese]
本发明属于化学药物技术领域，一种化合物A或其盐的无定型以及包含该无定形的药物组合物。